Niamh O'Hara is the co-founder and CEO of Biotia, a New York healthtech company that pairs next-generation DNA sequencing with AI to identify pathogens causing hard-to-diagnose infections. An evolutionary biologist by training, she spun the company out of Cornell Tech with Weill Cornell geneticist Christopher Mason, runs a CLIA-certified metagenomics lab in Long Island City, and is building what she calls a global microbial sequence database to catch outbreaks before they spread.

Alec Ford is the chief executive of Karius, a Redwood City genomics-diagnostics company that reads microbial cell-free DNA from a single tube of blood to identify more than a thousand pathogens. He took the job in October 2020 and led the company through a $100M Series C in May 2024.